Evidence map›Paper›PMID 40738972›Full record

ArticleNature biomedical engineering2026

Non-invasive characterization of pericyte dysfunction in mouse brain using functional ultrasound localization microscopy.

Jérémy H Thalgott, Nicolas Zucker, Thomas Deffieux, Marit S Koopman, Alexandre Dizeux, Cristina M Avramut, Roman I Koning, Hans-Jurgen Mager, Ton J Rabelink, Mickaël Tanter and 1 more

Erratum issuedAbstract read
In one paragraph

Article in Nature biomedical engineering, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

11 authors.

Jérémy H Thalgott *Einthoven Laboratory for Vascular and Regenerative Medicine, Department of Internal Medicine (Nephrology), Leiden University Medical Centre, Leiden, the Netherlands.ORCID http://orcid.org/0000-0002-0485-4025
Nicolas Zucker *Institute Physics for Medicine Paris, INSERM U1273, ESPCI Paris-PSL, CNRS UMR8063, Paris, France.ORCID http://orcid.org/0009-0005-6332-9094
Thomas DeffieuxInstitute Physics for Medicine Paris, INSERM U1273, ESPCI Paris-PSL, CNRS UMR8063, Paris, France.
Marit S KoopmanEinthoven Laboratory for Vascular and Regenerative Medicine, Department of Internal Medicine (Nephrology), Leiden University Medical Centre, Leiden, the Netherlands.
Alexandre DizeuxInstitute Physics for Medicine Paris, INSERM U1273, ESPCI Paris-PSL, CNRS UMR8063, Paris, France.
Cristina M AvramutEinthoven Laboratory for Vascular and Regenerative Medicine, Department of Internal Medicine (Nephrology), Leiden University Medical Centre, Leiden, the Netherlands.ORCID http://orcid.org/0000-0002-2399-1746
Roman I KoningDepartment of Cell and Chemical Biology, Electron Microscopy Facility, Leiden University Medical Centre, Leiden, the Netherlands.
Hans-Jurgen MagerDepartment of Pulmonology St Antonius Hospital, Nieuwegein, the Netherlands.
Ton J RabelinkEinthoven Laboratory for Vascular and Regenerative Medicine, Department of Internal Medicine (Nephrology), Leiden University Medical Centre, Leiden, the Netherlands.ORCID http://orcid.org/0000-0001-6780-5186
Mickaël Tanter *Institute Physics for Medicine Paris, INSERM U1273, ESPCI Paris-PSL, CNRS UMR8063, Paris, France. mickael.tanter@espci.fr.ORCID http://orcid.org/0000-0001-7739-8051
Franck Lebrin *Einthoven Laboratory for Vascular and Regenerative Medicine, Department of Internal Medicine (Nephrology), Leiden University Medical Centre, Leiden, the Netherlands. f.lebrin@lumc.nl.ORCID http://orcid.org/0000-0002-1650-6757

Funding

Agence Nationale de la Recherche (French National Research Agency) ANR-22-CE19-0034-03EC | EU Framework Programme for Research and Innovation H2020 | H2020 European Institute of Innovation and Technology (H2020 The European Institute of Innovation and Technology) 101070917Novo Nordisk Fonden (Novo Nordisk Foundation) NNF21CC0073729ZonMw (Netherlands Organisation for Health Research and Development) PTO 446002501
6 · The paper itself

Abstract

Early microscopic-scale pericyte dysfunction contributes to the initial stages of many neurological diseases and represents a strong candidate target for therapeutic intervention. A non-invasive imaging modality able to image microvascular alterations induced by pericyte dysfunction is needed. In addition, the development of pericyte-focused therapies remains challenging due to the lack of early biomarkers of disease progression. Here we show that cerebral microvascular alterations induced by pericyte dysfunction can be characterized non-invasively in mice using functional ultrasound localization microscopy (fULM). Depletion of endothelial endoglin in adult mice as a model of hereditary haemorrhagic telangiectasia, leads to pericyte detachment in the arteriole-capillary transition (ACT) zone. Imaging reveals that arteriolar capillaries have irregular shapes, increased diameters, reduced blood speed and neurovascular uncoupling mainly localized in the ACT zone. Transforming growth factor-β signalling activator C381 restores pericyte coverage and neurovascular response. Our study underscores the potential of fULM in characterizing early microvascular alterations. As super-resolution ultrasound transitions to the clinic, our data support its future use in monitoring pericyte-focused therapies in humans.

Indexed as

BrainPericytesAnimalsCapillariesEndoglinMaleMiceMice, Inbred C57BLUltrasonographyEndoglinEng protein, mouse

Identifiers

PMID40738972
PMCPMC12920088

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.